Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.13969 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Yulin He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hung Hom, China. Hauptthemen laut MEDLINE: Dimethyl Fumarate, Psoriasis, Multiple Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dimethyl fumarate (DMF) is an anti‐inflammatory and immunoregulatory medication used to treat multiple sclerosis (MS) and psoriasis. Its skin sensitization property precludes its topical use, which is unfortunate for the treatment of psoriasis. Isosorbide di‐(methyl fumarate) (IDMF), a novel derivative of DMF, was synthesized to circumvent this adverse reaction and unlock the potential of topical delivery, which could be useful for treating psoriasis in the subpopulation of psoriatic MS patients, as well as in the general population. Here, we compared its therapeutic potential of this non‐sensitizing derivative with DMF and its therapeutic version Diroximel in three skin‐ and neuroinflammation models: the lck‐GFP zebrafish, activated BV‐2 murine microglia and human T‐lymphocyte Jurkat cell line. The results provide a comparative evaluation of the bioactivity of these three related chemical entities in models relevant to skin and neuroinflammation and expose several therapeutic advantages unique to IDMF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hung Hom, China.
- Sunny BioDiscovery Inc., Santa Paula, CA, USA.
- Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hung Hom, China.
- PolyU-BGI Joint Research Centre for Genomics and Synthetic Biology in Global Ocean Resources, The Hong Kong Polytechnic University, Hung Hom, China.
- Sytheon (a Hallstar Company) Parsippany, NJ, USA.
ORCID-Profile: Krzysztof Bojanowski
Zitieren
APA
He, Y., Gong, G., Quijas, G., Lee, S. M., Chaudhuri, R. K., & Bojanowski, K. (2025). Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13969
Vancouver
He Y, Gong G, Quijas G, Lee SM, Chaudhuri RK, Bojanowski K. Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis. FEBS Open Bio. 2025. doi:10.1002/2211-5463.13969
BibTeX
@article{He2025,
author = {He, Yulin and Gong, Guiyi and Quijas, Geovani and Lee, Simon Ming-Yuen and Chaudhuri, Ratan K and Bojanowski, Krzysztof},
title = {Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.13969}
}
EUVIMED